By Ryan McBride Big Blue’s cloud has helped Swiss scientists in their hunt for clues about how certain bacteria form resistance against antibiotics and cause disease. It’s perhaps the latest case where the tech giant ($IBM) has been aiding life sciences concerns in managing and analyzing biological or clinical data in the cloud. For this …
by John Carroll Just about every big pharma or biotech company that has earned an unwelcome reputation for building huge and unproductive R&D empires is taking a page from the household products behemoth Procter & Gamble and joining the shift to “open innovation.” A new article in Mass High Tech explores how that trend is affecting several …
By John Carroll Medco has just put out a new report taking a look at the cancer drug pipeline, counting more than 900 experimental treatments now being studied. That makes cancer the biggest disease category in the drug development world, which is not too surprising given the high prices that newly approved oncology treatments can command. …
The Relay Innovation Engine aggregates scientific and market data in real-time and provides competitive business intelligence to life sciences professionals. The Relay Innovation Engine powers Business Development Live! (BD Live!) for Biotechnology & Pharmaceutical companies, and Technology Transfer Live! (TT Live!) for University Technology Transfer Offices......Read More